Sherin Farouk Hammad

Sherin Farouk Hammad

Auto-generated profile, based on publicly available information

Sherin Farouk Hammad

Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MMMokhtar Mabrouk
Mokhtar Mabrouk
SHSherin F. Hammad
Sherin F. Hammad
AAAya A. Abdella
Aya A. Abdella
FMFotouh Rashed Mansour
Fotouh Rashed Mansour


21 May 2007 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
SHSherin Farouk Hammad
Sherin Farouk Hammad
MMMokhtar Mohamed Mabrouk
Mokhtar Mohamed Mabrouk
AHAhmed Habib
Ahmed Habib
HEHamed Elfatatry
Hamed Elfatatry
Naoya KishikawaNaoya Kishikawa
Naoya Kishikawa
NKNaotaka Kuroda
Naotaka Kuroda


16 March 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAya A. Marie
Aya A. Marie
SHSherin F. Hammad
Sherin F. Hammad
MSMohamed Salim
Mohamed Salim
MEMahmoud M. Elkhodary
Mahmoud M. Elkhodary
AKAmira H. Kamal
Amira H. Kamal
A reversed-phase RP-HPLC method was developed for the simultaneous determination of metformin hydrochloride (MET), pioglitazone (PIO), and glimepiride (GLM) in their combined dosage forms and spiked human plasma. Quality risk management principles for determining the critical method parameters (CMPs) and fractional factorial design were made to screen CMPs and subsequently, the Box–Behnken design was employed. The analytical Quality by Design (AQbD) paradigm was used to establish the method operable design region (MODR) for the developed method depended on understanding the quality target product profile (QTPP), analytical target profile (ATP), and risk assessment for different factors that affect the method performance to develop an accurate, precise, cost-effective, and environmentally benign method. The separation was carried out using a mobile phase composed of methanol: 0.05 M potassium dihydrogen phosphate buffer pH 3.7 with 0.05% TEA (78:22, v/v). The flow rate was 1.2 mL/min. DAD detector was set at 227 nm. Linagliptin (LIN) was used as an internal standard. The proposed method was validated according to The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). The assay results obtained by using the developed method were statistically compared to those obtained by the reported HPLC method, and a satisfying agreement was observed.

3 November 2023 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
AAAya A Abdella
Aya A Abdella
AZAsmaa M Zaki
Asmaa M Zaki
SHSherin Hammad
Sherin Hammad
FMFotouh Rashed Mansour
Fotouh Rashed Mansour